Stock PROTAGONIST THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Protagonist Therapeutics Inc Nasdaq

Equities

US74366E1029

End-of-day quote Nasdaq
Other stock markets
- PTS - Intraday chart for Protagonist Therapeutics Inc
05-07 Protagonist Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-03 Protagonist Therapeutics Insider Sold Shares Worth $707,750, According to a Recent SEC Filing MT

Chart calendar Protagonist Therapeutics Inc

38efee63a7d820bdfd8dd14.9u1Mmx2mQkqsj2vZypHfRk-qDUfVWJPYLdRJagTNSWk.v4l16UnjDgD8-zuKiaKQayCaSBaZE-uSVbUBDEyFZAbOjxOuVMcJBtvWOg~b2fe3d4039e0042ced9c0bdd4ca61c88

Upcoming events on Protagonist Therapeutics Inc

2024-06-14 08:45 European Hematology Association Congress
2024-06-20 13:00 Annual General Meeting
2024-07-31 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-17 Q4 2024 Earnings Release (Projected)
2025-05-06 Q1 2025 Earnings Release (Projected)

Past events on Protagonist Therapeutics Inc

2024-05-14 14:45 Capital One Biotech/Biopharma Disruptors Conference - Panel
2024-05-13 14:00 Citizens JMP Life Sciences Conference - Fireside Chat
2024-05-08 16:05 Q1 2024 Earnings Release
2024-03-28 13:00 H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
2024-03-26 13:30 Napa Valley Biotech Forum
2024-03-11 Jefferies Biotech on the Bay Summit
2024-03-10 American Academy of Dermatology Meeting
2024-02-27 16:05 Q4 2023 Earnings Release
2024-02-08 09:00 Guggenheim Healthcare Talks Biotechnology Conference
2024-01-31 16:30 Business Update Call
2024-01-09 12:45 JPMorgan Healthcare Conference
2023-12-11 13:30 American Society of Hematology Meeting - Session Name: 634
2023-12-10 21:00 American Society of Hematology Meeting - Session Name: 634
2023-12-09 20:30 American Society of Hematology Meeting - Session Name: 113
2023-12-09 13:30 American Society of Hematology Meeting - Session Name: 904
2023-11-14 04:00 Jefferies London Healthcare Conference - Fireside Chat
2023-11-09 14:25 Truist Securities Healthcare Conference - Panel
2023-11-06 J.P. Morgan Equity Opportunities Forum
2023-11-06 11:10 Guggenheim Securities Inflammation & Immunology Conference - Fireside Chat
2023-11-02 00:00 Q3 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,23
1,74
-86.69%		28,6
25,7
11.45%		27,4
23,2
17.93%		26,6
31,4
-15.46%		60,0
30,0
100%
270

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-63,7
-68,7
7.22%		-125
-135
7.38%		0,00
0,00
- 		-92,7
-96,0
3.46%
82,0

EBIT
Million USD		Released
Forecast
Spread 		-80,5
-81,8
1.55%		-64,5
-65,4
1.29%		-126
-128
1.54%		-131
-125
-5.35%		-93,7
-127
26.5%
80,1

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-77,9
-79,3
1.83%		-64,8
-64,1
-1.11%		-126
-128
2.06%		-127
-127
-0.41%		-79,0
-116
31.76%
95,4

Net income
Million USD		Released
Forecast
Spread 		-77,2
-77,9
0.89%		-66,2
-66,2
0.04%		-126
-128
1.93%		-127
-123
-3.53%		-79,0
-115
31.24%
77,3

EPS
USD		Released
Forecast
Spread 		-2,98
-3,00
0.6%		-1,92
-1,94
0.84%		-2,71
-2,73
0.78%		-2,60
-2,49
-4.44%		-1,39
-2,02
31.28%
1,15

Announcement Date10/03/2010/03/2128/02/2215/03/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		25,7
17,1
50.86%		0,86
0,38
124.09%		0,00
0,00
- 		0,00
5,00
- 		0,00
1,67
- 		0,00
0,00
- 		0,00
0,00
- 		60,0
30,0
100%		255
120
112.46%
6,67


0,83


7,50


0,00


100

EBITDA
Million USD		Released
Forecast
Spread 		-20,9
-50,0
58.28%		-41,2
-52,0
20.8%		-32,0
-43,0
25.5%		-36,3
-33,0
-9.88%		-35,8
-37,0
3.32%		-42,1
-37,0
-13.83%		-38,1
-43,0
11.44%		23,3
21,0
10.94%		207
-38,0
643.54%
-44,0


-45,0


-36,0







EBIT
Million USD		Released
Forecast
Spread 		-21,1
-27,8
24.07%		-41,4
-46,3
10.55%		-32,3
-43,3
25.35%		-36,5
-29,0
-25.97%		-36,0
-36,3
0.65%		-42,4
-36,5
-15.94%		-38,3
-42,6
9.96%		23,0
-10,1
328.49%		206
36,9
458.72%
-39,8


-46,1


-40,3







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-20,9
-31,6
33.77%		-41,0
-48,9
16.01%		-31,2
-41,7
25.09%		-34,2
-33,6
-1.71%		-33,7
-33,5
-0.69%		-38,5
-35,0
-9.97%		-34,1
-39,7
14.11%		27,3
-8,04
440.04%		211
114
84.39%
-42,9


-43,3


-29,2







Net income
Million USD		Released
Forecast
Spread 		-20,9
-30,4
31.15%		-41,0
-45,9
10.65%		-31,2
-43,0
27.39%		-34,2
-29,4
-16.27%		-33,7
-35,9
6.05%		-38,5
-35,5
-8.2%		-34,1
-40,2
15.17%		27,3
-7,61
459.24%		207
39,3
427.28%
-44,8


-45,0


-37,0







EPS
USD		Released
Forecast
Spread 		-0,43
-0,63
31.57%		-0,84
-0,94
10.17%		-0,64
-0,87
26.31%		-0,69
-0,59
-16.49%		-0,67
-0,73
7.78%		-0,68
-0,65
-5.22%		-0,58
-0,69
16.27%		0,44
-0,14
406.9%		3,26
1,19
173.04%
-0,73


-0,73


-0,60


-0,77


0,62

Announcement Date04/05/2204/08/2208/11/2215/03/2304/05/2303/08/2302/11/2327/02/2407/05/24-----

Upcoming sector events for Protagonist Therapeutics Inc

2024-05-17 02:00 BIOARCTIC AB: Q1 2024 Earnings Release
2024-05-20 ALVOTECH: Q1 2024 Earnings Release
2024-05-21 07:00 EXSCIENTIA PLC: Q1 2024 Earnings Release
2024-05-21 CUREVAC N.V.: Q1 2024 Earnings Release (Projected)
2024-05-21 EVOTEC SE: Q1 2024 Earnings Release
2024-06-30 IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected)
2024-07-15 01:45 ADDLIFE AB: Q2 2024 Earnings Release
2024-07-21 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-23 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-23 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Protagonist Therapeutics Inc

Today REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected)
2024-05-14 GNI GROUP LTD.: Q1 2024 Earnings Release
2024-05-14 16:05 NUVATION BIO INC.: Q1 2024 Earnings Release
2024-05-14 07:30 ABSCI CORPORATION: Q1 2024 Earnings Release
2024-05-14 01:50 BELITE BIO, INC: Q1 2024 Earnings Release
2024-05-13 POLARIS GROUP: Q1 2024 Earnings Release
2024-05-13 16:30 AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-13 07:00 APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-12 19:00 PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release
2024-05-13 06:30 FORTREA HOLDINGS INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. Stock
  5. Calendar Protagonist Therapeutics Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW